<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Brainstorm Cell Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Chaim Lebovits
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc. is an innovative biopharmaceutical company committ...

    Proteostasis Therapeutics, Inc. is an innovativ...

    Filing Type:    PU
    Avedro, Inc

    Avedro, Inc

    We are committed to advancing the treatment of eye conditions such as keratoconus ...

    We are committed to advancing the treatment of ...

    Filing Type:    PU
    Cerner Corporation

    Cerner Corporation

    For 40 years, we’ve worked at the intersection of health care and information te...

    For 40 years, we’ve worked at the intersectio...

    Filing Type:    PU
    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow is here to change the way we think about artificial limbs. They...

    Unlimited Tomorrow is here to change the way we...

    Amount Raised:    $883,964.00
    Fundraising Status:    EC
    Filing Type:    CF
    Bio-Path Holdings, Inc.

    Bio-Path Holdings, Inc.

    Bio-Path is a biotechnology company developing targeted therapies for acute myeloi...

    Bio-Path is a biotechnology company developing ...

    Filing Type:    PU
    Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses o...

    Aeolus Pharmaceuticals, Inc. is a biopharmaceut...

    Amount Raised:    $18,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Caladrius Biosciences, Inc.

    Caladrius Biosciences, Inc.

    Caladrius is a clinical-stage biopharmaceutical company committed to the developme...

    Caladrius is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...

    Pluristem Therapeutics Inc. is a clinical-stage...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.